# Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

> **NCT06174402** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Han Ying** · enrollment: 184 (estimated)

## Conditions studied

- Primary Biliary Cholangitis

## Interventions

- **DRUG:** Fenofibrate
- **DRUG:** Placebo
- **DRUG:** UDCA

## Key facts

- **NCT ID:** NCT06174402
- **Lead sponsor:** Han Ying
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-21
- **Primary completion:** 2026-07
- **Final completion:** 2026-12-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06174402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06174402, "Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06174402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*